|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 25, 2021
|
|
|---|---|---|---|---|---|
| Net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Trade name impairment | |||||
| Loss (gain) on foreign denominated transactions | |||||
| Depreciation and amortization | |||||
| Goodwill impairment | |||||
| Share-based compensation expense | |||||
| (Gain) loss on foreign denominated transactions | |||||
| Loss (gain) on foreign currency derivatives | |||||
| (Gain) loss on sale and disposal of businesses, fixed assets, and sale leaseback transactions | |||||
| Loss on fair value of Seller Note | |||||
| Reclassification of interest rate hedge to income | |||||
| Bad debt expense | |||||
| Asset impairment charges and lease terminations | |||||
| Amortization of deferred financing costs and bond discounts | |||||
| Amortization of cloud computing | |||||
| Benefit for deferred income taxes | |||||
| Other, net | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts and notes receivable, net | |||||
| Inventory | |||||
| Prepaid and other assets | |||||
| Advertising fund assets and liabilities, restricted | |||||
| Other assets | |||||
| Deferred commissions | |||||
| Deferred revenue | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Income tax receivable | |||||
| Cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Cash used in business acquisitions, net of cash acquired | |||||
| Proceeds from sale leaseback transactions | |||||
| Proceeds from Seller Note | |||||
| Proceeds from sale or disposal of businesses and fixed assets, net of cash sold | |||||
| Cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment of debt extinguishment and issuance costs | |||||
| Proceeds from the issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Proceeds from revolving lines of credit and short-term debt | |||||
| Repayment of revolving lines of credit and short-term debt | |||||
| Repayment of principal portion of finance lease liability | |||||
| Proceeds from failed sale-leaseback transactions | |||||
| Proceeds from initial public offering, net of underwriting discounts | |||||
| Net proceeds from follow-on public offering | |||||
| Payment of Tax Receivable Agreement | |||||
| Acquisition of non-controlling interest | |||||
| Share repurchases | |||||
| Proceeds from the termination of interest rate swap | |||||
| Payment for termination of interest rate swaps | |||||
| Tax obligations for share-based compensation | |||||
| Stock option exercises | |||||
| Other, net | |||||
| Cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash, cash equivalents, restricted cash, and cash included in advertising fund assets, restricted | |||||
| Cash and cash equivalents from continuing operations, beginning of period | |||||
| Cash included in advertising fund assets, restricted, beginning of period | |||||
| Restricted cash from continuing operations, beginning of period | |||||
| Cash, cash equivalents, and restricted cash from discontinued operations, beginning of period | |||||
| Cash, cash equivalents, restricted cash, and cash included in advertising fund assets, restricted, beginning of period | |||||
| Cash and cash equivalents from continuing operations, end of period | |||||
| Cash included in advertising fund assets, restricted, end of period | |||||
| Restricted cash from continuing operations, end of period | |||||
| Cash, cash equivalents, and restricted cash from discontinued operations, end of period | |||||
| Cash, cash equivalents, restricted cash, and cash included in advertising fund assets, restricted, end of period | |||||
| Supplemental cash flow disclosures - non-cash items: | |||||
| Capital expenditures included in accrued expenses and other liabilities | |||||
| Working capital adjustments included in accrued expenses and other liabilities | |||||
| Deferred consideration included in accrued expenses and other liabilities | |||||
| Contingent consideration | |||||
| Proceeds from sale of fixed assets included in accounts and notes receivable, net | |||||
| Supplemental cash flow disclosures - cash paid for: | |||||
| Interest | |||||
| Income taxes | |||||
Loading...